Haemorheology and Cellular Interactions

Rampling M. Haemorheology and blood flow in diabetes and limb ischaemia. J Roy Soc Med 1985; 78: 596–8.

Jones JG. New aspects of red cell aggregation. J Roy Soc Med 1990; 83: 663–4.

Bauersachs RM Shaw SJ Zeidler A Meiselman HJ. Red blood cell aggregation and blood viscoelasticity in poorly controlled Type 2 diabetes mellitus. Clin Hemorheol 1989; 9: 935–52.

McMillan DE. Hemorheologic therapy to control diabetic vascular disease. Clin Hemorheol 1992; 12: 787–96.

Othmane A Bitbol M Snabre P Mills P Grimaldi A Bosquet F. Red cell aggregation in insulin-dependent diabetics. Clin Hemorheol 1989; 9: 281–96.

Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991:465.

Stuart J Stone PCW Freyburger G Boisseau MR Altman DG. Instrument precision and biological variability determine the number of patients required for rheological studies. Clin Hemorheol 1989; 9: 181–98.

Nash GB. White blood cell rheology and atherosclerotic ischaemic disease. Clin Hemorheol 1992; 12: 57–70.

Evans S-A Jones JG Wardrop CAJ Lane I. Leukocyte filterability in peripheral vascular disease. Clin Hemorheol 1993; 13: 73–82.

Schmid-Schonbein H Goslinga H. The present state of hemodilutional therapies: Potentials and limits of the most potent tool of ‘clinical hemorheology’. Clin Hemorheol 1992; 12: 883–902.